NCT04486976

Comparative Study of the Cornea/Anterior Segment OCT CASIA2 and the RTVue XR OCT Avanti With AngioVue Software

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 134 (actual)
• Sponsor: Tomey Corporation · Industry
• Sex: All
• Age: 22 Years
• Healthy volunteers: Accepted

Summary

This study is a prospective comparative, randomized, single center study to gather agreement and precision data in all subjects.

Conditions

• Glaucoma
• Cataract

Interventions

Type	Name	Description
DEVICE	Cornea/Anterior Segment OCT CASIA2	Cornea/Anterior Segment OCT CASIA2 The Tomey Cornea/Anterior Segment OCT CASIA2 is a non-contact, high resolution tomographic and biomicroscopic device indicated for the in vivo imaging and measurement of ocular structures in the anterior segment, such as corneal thickness. The Tomey Cornea/Anterior Segment OCT CASIA2 is indicated as an aid in the visualization of anterior segment findings.
DEVICE	Optovue RTVue XR Avanti	Optovue RTVue XR Avanti The Avanti is an optical coherence tomography system indicated for the in vivo imaging,axial cross-sectional, and three-dimensional imaging and measurement of anterior and posterior ocular structures.

Timeline

• Start date: 2020-06-27
• Primary completion: 2021-03-05
• Completion: 2021-03-05
• First posted: 2020-07-27
• Last updated: 2021-08-30

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study